News
Jinlangbo Pharmaceutical participated in the IPPE exhibition in the United States
Release time:
2025-02-11
From January 28th to 30th, 2025, the global poultry, feed, and meat processing industry's grand event, the IPPE2025 exhibition, was held at the Georgia World Congress Center in Atlanta. This edition of IPPE focused on topics such as animal nutrition and sustainable development, bringing together 1,427 exhibitors and 31,000 professional visitors from over 130 countries.
The overseas marketing team of Jinlangbo Pharmaceutical participated in this grand event with its star product, 25-hydroxyvitamin D3, and conducted in-depth exchanges with customers from dozens of countries and regions including North America, Latin America, Europe, and Asia. They demonstrated to global customers the promising application prospects of 25-hydroxyvitamin D3 products and the company's core competitiveness in the "full industry chain of 25-hydroxyvitamin D3", leaving a deep impression on the customers.
Since its launch, the company's 25-hydroxyvitamin D3 product has been successfully exported to over 10 countries and regions worldwide, including North America, Europe, Asia, and Latin America. It has successively obtained certifications from the EU's FAMI-QS, ISO9001, and ISO22000 systems. The brand-new synthetic biology process has been granted two national patents, giving the company a core competitiveness. The company will continue to deepen its cooperation with customers in the international market, continuously injecting the power of "China's intelligent manufacturing" into the global animal nutrition industry.
More news
Address: No. 53 Yulin Road, Yulin Street, Xinchang County, Zhejiang Province
Tel: +86-575-86297308 +86-575-86297565
Fax: 0575-86297657
Email: jinlangbo@jingxinpharm.com